Patient characteristics, aneurysmal specifics, technical aspect of the procedure, and antiplatelet drug reactivity associated with multiple diffusion-positive lesions in patients undergoing endovascular treatment of unruptured intracranial aneurysms
| Categorya | Grade 0/I (n = 49) | Grade II (n = 9) | Puni | Plogistic | |
|---|---|---|---|---|---|
| Sex | Male (23, 39.7%) | 20 | 3 | 1.000 | |
| Female (35, 60.3%) | 29 | 6 | |||
| Age (years) | ≤ 60 (35, 60.3%) | 30 | 5 | 1.000 | |
| > 60 (23, 39.7%) | 19 | 4 | |||
| HTN | Yes (23, 39.7%) | 20 | 3 | 1.000 | |
| DM | Yes (4, 6.9%) | 4 | 0 | 1.000 | |
| Dyslipidemia | Yes (11, 19.0%) | 8 | 3 | .350 | |
| CAD | Yes (3, 5.2%) | 2 | 1 | .403 | |
| Stroke | Yes (6, 10.3%) | 4 | 2 | .231 | |
| Statin | Yes (11, 19.0%) | 8 | 3 | .350 | |
| Aspirin | Yes (19, 32.8%) | 16 | 3 | 1.000 | |
| Smoking | Yes (15, 25.9%) | 13 | 2 | 1.000 | |
| Dome size | <7 mm (39, 67.2%) | 34 | 5 | .456 | |
| ≥7 mm (19, 32.8%) | 15 | 4 | |||
| Neck width | <4 mm (32, 55.2%) | 28 | 4 | .717 | |
| ≥4 mm (26, 44.8%) | 21 | 5 | |||
| Multiplicity of the procedureb | Single (54, 93.1%) | 48 | 6 | .010 | .051 |
| Double (4, 6.9%) | 1 | 3 | |||
| Procedural methods | Single (16, 27.6%)c | 15 | 1 | .088 | .642 |
| Double (18, 41.4%)c | 17 | 1 | |||
| Stent (24, 31%) | 17 | 7 | |||
| Aspirin resistance | Yes (9, 15.5%) | 8 | 1 | 1.000 | .667 |
| Clopidogrel resistance | Yes (23, 39.7%) | 15 | 8 | .002 | .014 |